Neuroone Medical Technologies Corp reports results for the quarter ended in March - Earnings Summary

Neuroone Medical Technologies

11/05/2023 21:43

* Neuroone Medical Technologies Corp  NMTC.OQ  reported a
quarterly adjusted loss of 21 cents​​ per share for the quarter
ended in March. The mean expectation of two analysts for the
quarter was for a loss of 20 cents per share.
    * Revenue rose 1,173.9% to $466.00 thousand from a year ago;
analysts expected $250.00 thousand. 
    * Neuroone Medical Technologies Corp's reported EPS for the
quarter was a loss of 21 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Neuroone Medical Technologies Corp shares had fallen
by 16.1%
this quarter and gained 12.5% so far this year.
    * The company reported a quarterly loss of $3.52 million.
    * Wall Street's median 12-month price target for Neuroone
Medical
Technologies Corp is $2.63 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 08:43 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.20          -0.21          Missed
 Dec. 31 2022      -0.11          -0.11          Met
 Sep. 30 2022      -0.11          -0.09          Beat
 Jun. 30 2022      -0.22          -0.17          Beat